MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0296549
Medimount Pharmaceuticals Private Limited
Medimount Pharmaceuticals Private Limited - chemicals in Badlapur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹14.98 Lakh
▼ 60% YoY
Net profit · FY 2023
₹18,338
Net margin 1.2%
EBITDA · FY 2023
₹1.2 Lakh
EBITDA margin 8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹7 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Medimount Pharmaceuticals Private Limited
Data last updated:
Medimount Pharmaceuticals Private Limited is a private limited company based in Badlapur, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2019PTC322145. Its GSTIN is 20AAMCM4992L1Z0 (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kumari Sangita Singh and Rinki Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D 607 Phase 111 Sashwat Park Valivli, Badlapur, Maharashtra, India – 421503.
As per the financials filed for FY 2023, the company reported a revenue of ₹14.98 Lakh, a decline of 60% compared to the previous year. For the same year it recorded a net profit of ₹18,338 (net margin 1.2%) and EBITDA of ₹1.2 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
Medimount Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0296549).
Company details
CIN U24230MH2019PTC322145
Registration Number 322145
Incorporation Date 05 March 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0296549
Recognitions & Rankings of Medimount Pharmaceuticals
Contact details
Medimount Pharmaceuticals Private Limited's registered office is in Badlapur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD 607 Phase 111 Sashwat Park Valivli, Badlapur, Maharashtra, India – 421503
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Medimount Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medimount Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medimount Pharmaceuticals is manufacturing. In detail, this covers manufacture of food products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 10 | Manufacture of food products |
To see the full business activity and turnover split of Medimount Pharmaceuticals Private Limited, buy the company report.
Financials of Medimount Pharmaceuticals Private Limited
FY 2025 filings availableMedimount Pharmaceuticals Private Limited reported revenue of ₹14.98 Lakh (down 60% YoY) for FY 2023.
Revenue · FY 2023
₹14.98 Lakh ▼ 60%
Net profit · FY 2023
₹18,338 margin 1.2%
EBITDA · FY 2023
₹1.2 Lakh margin 8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 60%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 27%
Revenue fell 60% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18,338 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medimount Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medimount Pharmaceuticals Private Limited
Medimount Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumari Sangita Singh | Director | 05 Mar 2019 | 7 Years 8 Months | Current |
| Rinki Singh Also directs: Medimount Lifesciences (OPC) Private Limited | Director | 05 Mar 2019 | 7 Years 8 Months | Current |
Charges & borrowings
Open charges
₹7 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2019 | 100277903 | Others | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medimount Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medimount Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medimount Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAMCM4992L1Z0 | Jharkhand | Active | 28 Mar 2019 |
To see the full GST registrations and return filing status of Medimount Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medimount Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Kumari Sangita Singh was appointed as Director on 05 Mar 2019.
AGM
Medimount Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medimount Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 7.00 Lakh with Charge ID 100277903 was registered on 20 Jul 2019.
Appointed
Kumari Sangita Singh was appointed as Director.
Appointed
Rinki Singh was appointed as Director.
Incorporation
05 Mar 2019
Medimount Pharmaceuticals Private Limited was registered on 05 Mar 2019 with Roc Mumbai Ii & aged 7 years 8 months as per MCA records.
Frequently asked questions
Medimount Pharmaceuticals is an active private limited company based in Badlapur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 March 2019 (7+ years old) and is registered under CIN U24230MH2019PTC322145.
Medimount Pharmaceuticals has 2 current directors:
- Kumari Sangita Singh - Director
- Rinki Singh - Director
The latest financial statements of Medimount Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medimount Pharmaceuticals is 20AAMCM4992L1Z0, registered in Jharkhand.
The CIN (Corporate Identification Number) of Medimount Pharmaceuticals is U24230MH2019PTC322145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medimount Pharmaceuticals was incorporated on 05 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Kumari Sangita Singh was appointed as Director on 05 Mar 2019. Rinki Singh was appointed as Director on 05 Mar 2019.
Yes, Medimount Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0296549).
The registered office of Medimount Pharmaceuticals is at D 607 Phase 111 Sashwat Park Valivli, Badlapur, Maharashtra, India – 421503.
Medimount Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages